Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
Recap by typeshit. Full story at Inside Retail Asia.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
NewBeauty profiles the New York doctor, who says she began using GLP-1 drugs off-label for weight management about 20 years ago.
EMY covers findings suggesting GLP-1 drugs such as Wegovy could lower the risk of certain cancers. Details on which cancers are in the full story.
A short Facebook clip where a doctor urges people on GLP-1 drugs to check their blood pressure. Details beyond the title are thin.
Loading…